For: | Gandhi P, Khare R, Niraj K, Garg N, Sorte SK, Gulwani H. Unique case of oligoastrocytoma with recurrence and grade progression: Exhibiting differential expression of high mobility group-A1 and human telomerase reverse transcriptase. World J Clinical Cases 2016; 4(9): 296-301 [PMID: 27672647 DOI: 10.12998/wjcc.v4.i9.296] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v4/i9/296.htm |
Number | Citing Articles |
1 |
Puneet Gandhi, Richa Khare, Nitin Garg, Jharna Mishra. Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?. Journal of Cancer Research and Therapeutics 2022; 18(1): 224 doi: 10.4103/jcrt.jcrt_1900_20
|
2 |
Puneet Gandhi, Richa Khare, Nitin Garg. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?. Journal of Neuro-Oncology 2017; 135(2): 255 doi: 10.1007/s11060-017-2578-6
|
3 |
Puneet Gandhi, Richa Khare, Nitin Garg, Sandeep Sorte. Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival. World Journal of Clinical Cases 2017; 5(6): 247-253 doi: 10.12998/wjcc.v5.i6.247
|
4 |
Puneet Gandhi, Richa Shrivastava, Nitin Garg, Sandeep K Sorte. Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients . World Journal of Clinical Oncology 2021; 12(10): 947-959 doi: 10.5306/wjco.v12.i10.947
|
5 |
Kavita Peter, Puneet Gandhi, Santosh Kumar Kar. Curcumin and 2-DG synergistically target the glio-oncogenesis trigger IL-6 and down-regulate the stemness in glioblastoma model in-vitro. Advances in Traditional Medicine 2024; doi: 10.1007/s13596-024-00800-y
|